Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Medicine info: Active ingredients
Need more information?
These trusted information partners have more on this topic.
Top results
TGA grants provisional approval to Gilead Sciences Pty Ltd to extend the use of the COVID-19 treatment, VEKLURY (remdesivir) | Therapeutic Goods Administration (TGA)
The TGA has granted provisional approval to Gilead Sciences Pty Ltd to extend the use of the COVID-19 treatment, VEKLURY (remdesivir).
Read more on TGA – Therapeutic Goods Administration website
TGA provisionally approves two oral COVID-19 treatments, molnupiravir (LAGEVRIO) and nirmatrelvir + ritonavir (PAXLOVID) | Therapeutic Goods Administration (TGA)
The TGA has granted provisional approval to two oral COVID-19 treatments.
Read more on TGA – Therapeutic Goods Administration website
What you need to know about COVID-19 - Immunisation Coalition
What you need to know about COVID-19 so you can protect yourself, your friends, family and the rest of the community.
Read more on Immunisation Coalition website
Top results
Oral antivirals for mild–moderate COVID‑19: a panacea or a logistical and clinical conundrum?
The new oral antiviral drugs for COVID-19 were mainly studied in unvaccinated patients, before the emergence of the Omicron variant. Will they still be of benefit in 2022?
Read more on Australian Prescriber website